Control of postprandial hyperglycemia in type 1 diabetes by 24-hour fixed-dose coadministration of pramlintide and regular human insulin: A randomized, two-way crossover study
Riddle MC et al. Diabetes Care 2018: dc181091. doi: 10.2337/dc18-1091
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.